Resources
2 Results (showing 1 - 2)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 1/17/2023 (updated 3/27/2024)
The Consolidated Appropriations Act of 2023 removed the federal requirement for providers to have an X-waiver to prescribe medications for the treatment of OUD. The act amended the Controlled Substances Act. Depending on state law, practitioners who have a current DEA registration with Schedule III authority will be able to prescribe buprenorphine for OUD starting now.
Posted 8/10/2022 (updated 3/27/2024)
In August 2022, HRSA announced investments of nearly $60 million in combined awards across five programs to increase access to quality health care in rural communities. These programs address workforce shortages, the sustainability of small rural hospitals, and high quality care to rural veterans.